Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,417
datasets available to search
ShareScore release 0.9.0
Dataset results
2,417 results for “Stenting”
Endovascular Treatment of Wide Neck Intracranial Aneurysms With the LEO + Stent : The LEO + II Cohort Study
ClinicalTrials.gov study NCT03504436. IPD Sharing: NO. Countries: 0. Publications: 0.
Results of the Treatment of Medium and Long de Novo and Restenotic Lesions in the Superficial Femoral Artery and/or Popliteal Artery With Primary or Salvage Pulsar® -18 t3 Stent
ClinicalTrials.gov study NCT05665816. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Sirolimus With corTicOsteroid TheraPy for Rapid rEcurrences of Coronary Unexplained In-stent Restenosis
ClinicalTrials.gov study NCT06981845. IPD Sharing: NO. Countries: 0. Publications: 0.
Establish a Telecare Model of Acute Coronary Syndrome Patient With Heart Stent Implantation by a Non-invasive Wearable Device and Artificial Intelligence Cloud to Reducing Medical Adverse Events.
ClinicalTrials.gov study NCT04455568. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Tangji EU Gastric Bypass Stent Study for Obesity
ClinicalTrials.gov study NCT05249608. IPD Sharing: NO. Countries: 0. Publications: 0.
Evaluation of Short Term Outcome of Different Bifurcation Stenting Techniques at Assuit University Cath. Lab
ClinicalTrials.gov study NCT03266289. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Treatment of Acute Ischemic Stroke With CATCHVIEW Stent Retriever in Comparison to SOLITAIRE 2/FR
ClinicalTrials.gov study NCT03754296. IPD Sharing: NO. Countries: 0. Publications: 0.
Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study)
ClinicalTrials.gov study NCT00287508. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Comparative Analysis of Stented Biological Prosthesis Versus Aortic Allograft in Patients With Degenerative Aortic Valve Disease
ClinicalTrials.gov study NCT07210541. IPD Sharing: NO. Countries: 0. Publications: 0.
CT-FFR-guided Strategy for In-stent Restenosis
ClinicalTrials.gov study NCT05611190. IPD Sharing: NO. Countries: 0. Publications: 0.
Randomized Controlled Trial of Internal Fixation Reconstruction With Stent Screw in the Treatment of Kummell's Disease
ClinicalTrials.gov study NCT06093087. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric Population
ClinicalTrials.gov study NCT02483793. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Postapproval Trial On Carotid Stenting in Patients With High Risk Vs Standard Risk for Open Carotid Endarterectomy(REAL)
ClinicalTrials.gov study NCT02750644. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
REWARDS-Angina at Follow up Post Stenting
ClinicalTrials.gov study NCT02455817. IPD Sharing: Not stated. Countries: 0. Publications: 0.
DXR Stent(Previous Cilotax) Implantation Registry
ClinicalTrials.gov study NCT01612819. IPD Sharing: NO. Countries: 1. Publications: 0.
Xiangtong TM Full Degradation Sinus Drug Stent System Prospective, Open, Single-center, Randomized Controlled Clinical Trial
ClinicalTrials.gov study NCT06669130. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Drug Eluting Stent Zilver PTX vs Bare Metal Stent Zilver Flex
ClinicalTrials.gov study NCT05296031. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Effect of Different Anti-platelet Strategies on the Long-term Outcome After Sirolimus Drug-eluting Stent Implantation
ClinicalTrials.gov study NCT01233167. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Development of gene expression signatures for In-stent Restenosis
GEO Series GSE182225. Homo sapiens. 6 samples. Type: Expression profiling by array; Non-coding RNA profiling by array.
Dataset related to article "One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk Patients"
<p>This record contains raw data related to article "One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk Patients"</p> <p>Abstract:</p> <p>Background It is unknown whether contemporary drug-eluting stents have a similar safety profile in high bleeding risk patients treated with 1-month dual antiplatelet therapy following percutaneous coronary interventions. Methods and Results We performed an interventional, prospective, multicenter, single-arm trial, powered for noninferiority with respect to an objective performance criterion to evaluate the safety of percutaneous coronary interventions with Synergy bioresorbable-polymer everolimus-eluting stent followed by 1-month dual antiplatelet therapy in patients with high bleeding risk. In case of need for an oral anticoagulant, patients received an oral anticoagulant in addition to a P2Y<sub>12</sub> inhibitor for 1 month, followed by an oral anticoagulant only. The primary end point was the composite of cardiac death, myocardial infarction, or definite or probable stent thrombosis at 1-year follow-up. The study was prematurely interrupted because of slow recruitment. From April 2017 to October 2019, 443 patients (age, 74.8±9.2 years; women, 29.1%) at 10 Italian centers were included. The 1-year primary outcome occurred in 4.82% (95% CI, 3.17%-7.31%) of patients, meeting the noninferiority compared with the predefined objective performance criterion of 9.4% and the noninferiority margin of 3.85% (<em>P<sub>noninferiority</sub></em><0.001) notwithstanding the lower-than-expected sample size. The rates of cardiac death, myocardial infarction, and definite or probable stent thrombosis were 1.88% (95% CI, 0.36%-2.50%), 3.42% (95% CI, 2.08%-5.62%), and 0.94% (95% CI, 0.35%-2.49%), respectively. Conclusions Among high bleeding risk patients undergoing percutaneous coronary interventions with the Synergy bioresorbable-polymer everolimus-eluting stent, a 1-month dual antiplatelet therapy regimen is safe, with low rates of ischemic and bleeding events. Registration URL: https://www.clinicaltrials.gov; Unique identifier: <a href="http://clinicaltrials.gov/show/NCT03112707">NCT03112707</a>.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.